CNCK vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 05, 2026

CNCK

58.2
AI Score
VS
HIVE Wins

HIVE

59.4
AI Score

Investment Advisor Scores

CNCK

58score
Recommendation
HOLD

HIVE

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNCK HIVE Winner
Forward P/E 18.4502 40.1606 CNCK
PEG Ratio 0 0 Tie
Revenue Growth 16.5% 218.6% HIVE
Earnings Growth -68.9% -99.9% CNCK
Tradestie Score 58.2/100 59.4/100 HIVE
Profit Margin 0.0% -48.6% CNCK
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.